Ost-müük Dechra Pharmaceuticals PLC - DPH CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.22 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.023178% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.00126% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | GBP | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United Kingdom of Great Britain and Northern Ireland | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Dechra Pharmaceuticals PLC ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Eelmine sulgemine* | 33.11 |
Avatud* | 36.43 |
Aastane muutus* | 3% |
Päeva ulatus* | 36.25 - 36.49 |
52 nädala ulatus | 24.73-40.00 |
Keskmine maht (10 päeva) | 2.14M |
Keskmine maht (3 kuud) | 23.65M |
Turukapitalisatsioon | 4.14B |
P/E suhtarv | 101.18 |
Ringluses olevad aktsiad | 113.88M |
Tulu | 726.80M |
EPS | 0.36 |
Dividendid (% kasumist) | 1.24972 |
Beeta | 0.94 |
Järgmine tuluaruande kuupäev | Sep 4, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Jun 2, 2023 | 36.31 | -0.06 | -0.16% | 36.37 | 36.61 | 36.19 |
Jun 1, 2023 | 33.11 | -0.20 | -0.60% | 33.31 | 34.99 | 33.11 |
May 31, 2023 | 33.33 | 0.18 | 0.54% | 33.15 | 34.23 | 32.97 |
May 30, 2023 | 33.53 | 1.94 | 6.14% | 31.59 | 34.04 | 31.59 |
May 26, 2023 | 31.15 | -0.38 | -1.21% | 31.53 | 31.89 | 31.15 |
May 25, 2023 | 31.67 | 0.42 | 1.34% | 31.25 | 32.03 | 30.90 |
May 24, 2023 | 30.58 | -0.87 | -2.77% | 31.45 | 31.97 | 30.30 |
May 23, 2023 | 31.41 | -0.14 | -0.44% | 31.55 | 32.45 | 31.35 |
May 22, 2023 | 31.35 | -3.24 | -9.37% | 34.59 | 34.79 | 31.13 |
May 19, 2023 | 36.36 | -0.20 | -0.55% | 36.56 | 36.64 | 36.21 |
May 18, 2023 | 36.19 | -0.05 | -0.14% | 36.24 | 36.47 | 35.99 |
May 17, 2023 | 36.09 | -0.33 | -0.91% | 36.42 | 36.49 | 36.01 |
May 16, 2023 | 36.51 | -0.39 | -1.06% | 36.90 | 36.97 | 36.47 |
May 15, 2023 | 36.90 | 0.24 | 0.65% | 36.66 | 37.26 | 36.33 |
May 12, 2023 | 37.29 | -0.13 | -0.35% | 37.42 | 37.53 | 37.27 |
May 11, 2023 | 37.42 | 0.46 | 1.24% | 36.96 | 37.70 | 36.96 |
May 10, 2023 | 37.09 | 0.59 | 1.62% | 36.50 | 37.66 | 36.36 |
May 9, 2023 | 36.53 | -0.27 | -0.73% | 36.80 | 36.83 | 36.15 |
May 5, 2023 | 36.91 | 0.01 | 0.03% | 36.90 | 37.09 | 36.80 |
May 4, 2023 | 36.90 | 0.26 | 0.71% | 36.64 | 37.03 | 36.27 |
Dechra Pharmaceuticals PLC Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Tuesday, July 11, 2023 | ||
Kellaaeg (UTC) (UTC) 06:00 | Riik GB
| Sündmus Dechra Pharmaceuticals PLC Trading Statement Release Dechra Pharmaceuticals PLC Trading Statement ReleaseForecast -Previous - |
Monday, September 4, 2023 | ||
Kellaaeg (UTC) (UTC) 06:00 | Riik GB
| Sündmus Full Year 2023 Dechra Pharmaceuticals PLC Earnings Release Full Year 2023 Dechra Pharmaceuticals PLC Earnings ReleaseForecast -Previous - |
Thursday, October 19, 2023 | ||
Kellaaeg (UTC) (UTC) 06:00 | Riik GB
| Sündmus Dechra Pharmaceuticals PLC Trading Statement Release Dechra Pharmaceuticals PLC Trading Statement ReleaseForecast -Previous - |
Friday, October 20, 2023 | ||
Kellaaeg (UTC) (UTC) 10:59 | Riik GB
| Sündmus Dechra Pharmaceuticals PLC Annual Shareholders Meeting Dechra Pharmaceuticals PLC Annual Shareholders MeetingForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 681.8 | 608 | 515.1 | 481.8 | 407.1 |
Tulu | 681.8 | 608 | 515.1 | 481.8 | 407.1 |
Kulud, Kokku | 296.5 | 262.1 | 223.5 | 203.6 | 179.6 |
Brutokasum | 385.3 | 345.9 | 291.6 | 278.2 | 227.5 |
Kogu tegevuskulu | 599.8 | 521.2 | 465.4 | 443.8 | 372.5 |
Müük/Üldine/admin kulud, kokku | 178.6 | 151.3 | 134.9 | 125.7 | 110 |
Uuringud ja arendus | 32.4 | 32.4 | 28.4 | 25.1 | 18.3 |
Depreciation / Amortization | 72.8 | 75.2 | 69.6 | 76.8 | 54.1 |
Ootamatud kulutused (tulu) | 19.5 | 0.2 | 9 | 12.6 | 10.5 |
Tulud majandustegevusest | 82 | 86.8 | 49.7 | 38 | 34.6 |
Intressitulud (kulu), muud tulud, neto | -4.4 | -12.8 | -8.8 | -10.2 | -5.6 |
Muud, neto | 0 | -0.1 | |||
Netotulu enne makse | 77.6 | 74 | 40.9 | 27.8 | 28.9 |
Netotulu pärast makse | 58.2 | 55.5 | 33.9 | 20.9 | 26.1 |
Vähemuse intress | 0 | 0 | |||
Netotulu enne erikulusid | 58.2 | 55.5 | 33.9 | 20.9 | 26.1 |
Netotulu | 58.2 | 55.5 | 33.9 | 30.9 | 36.1 |
Arvestatav tulu, v a erikulud | 58.2 | 55.5 | 33.9 | 20.9 | 26.1 |
Arvestatav tulu, koos erikuludega | 58.2 | 55.5 | 33.9 | 30.9 | 36.1 |
Jaotuse korrigeerimine | 0 | 0 | |||
Jaotamisele kuuluv netotulu | 58.2 | 55.5 | 33.9 | 30.9 | 36.1 |
Keskmine jaotamisele kuuluv aktsia kohta | 108.987 | 108.751 | 103.482 | 102.762 | 97.4512 |
Jaotatav EPS, v a erakorralised kulud | 0.53401 | 0.51034 | 0.32759 | 0.20338 | 0.26783 |
Dividends per Share - Common Stock Primary Issue | 0.4489 | 0.405 | 0.3429 | 0.316 | 0.255 |
Jaotamisele kuuluv normaal-EPS | 0.95974 | 0.72643 | 0.58561 | 0.59847 | 0.64648 |
Erakorralised kulud kokku | 10 | 10 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Kogutulu | 377.4 | 349.4 | 332.4 | 308.2 | 299.8 |
Tulu | 377.4 | 349.4 | 332.4 | 308.2 | 299.8 |
Kulud, Kokku | 158.1 | 153.3 | 143.2 | 133 | 129.1 |
Brutokasum | 219.3 | 196.1 | 189.2 | 175.2 | 170.7 |
Kogu tegevuskulu | 339.8 | 324.2 | 275.6 | 262.9 | 258.3 |
Müük/Üldine/admin kulud, kokku | 102.5 | 96.8 | 81.8 | 76.5 | 74.8 |
Uuringud ja arendus | 26.5 | 18.9 | 13.5 | 17.3 | 15.1 |
Depreciation / Amortization | 38.6 | 37.4 | 35.4 | 36.9 | 38.3 |
Ootamatud kulutused (tulu) | 14.1 | 17.8 | 1.7 | -0.8 | 1 |
Tulud majandustegevusest | 37.6 | 25.2 | 56.8 | 45.3 | 41.5 |
Intressitulud (kulu), muud tulud, neto | -7.9 | -1 | -3.4 | -6.7 | -6.1 |
Muud, neto | |||||
Netotulu enne makse | 29.7 | 24.2 | 53.4 | 38.6 | 35.4 |
Netotulu pärast makse | 22.6 | 17.5 | 40.7 | 32.2 | 23.3 |
Netotulu enne erikulusid | 22.6 | 17.5 | 40.7 | 32.2 | 23.3 |
Netotulu | 22.6 | 17.5 | 40.7 | 32.2 | 23.3 |
Arvestatav tulu, v a erikulud | 22.6 | 17.5 | 40.7 | 32.2 | 23.3 |
Arvestatav tulu, koos erikuludega | 22.6 | 17.5 | 40.7 | 32.2 | 23.3 |
Jaotuse korrigeerimine | 0 | ||||
Jaotamisele kuuluv netotulu | 22.6 | 17.5 | 40.7 | 32.2 | 23.3 |
Keskmine jaotamisele kuuluv aktsia kohta | 113.824 | 109.083 | 108.892 | 108.803 | 108.698 |
Jaotatav EPS, v a erakorralised kulud | 0.19855 | 0.16043 | 0.37376 | 0.29595 | 0.21436 |
Dividends per Share - Common Stock Primary Issue | 0.125 | 0.3289 | 0.12 | 0.2939 | 0.1111 |
Jaotamisele kuuluv normaal-EPS | 0.42873 | 0.49595 | 0.46376 | 0.46598 | 0.26035 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 444.4 | 392.2 | 448.9 | 291.5 | 247.9 |
Raha ja lühiajalised investeeringud | 120.9 | 118.4 | 227.4 | 80.3 | 79.7 |
Cash | 120.9 | 118.4 | 227.4 | 80.3 | 79.7 |
Lühiajalised investeeringud | |||||
Laekumata arved, neto | 142.1 | 119.2 | 97.3 | 103.8 | 79 |
Accounts Receivable - Trade, Net | 122.1 | 88.2 | 79.4 | 91.1 | 76 |
Total Inventory | 175.7 | 149.5 | 120.8 | 103.5 | 86.6 |
Prepaid Expenses | 5.7 | 5.1 | 3.4 | 3.9 | 2.6 |
Total Assets | 1293.3 | 1214.1 | 1237.6 | 1041.5 | 1017.3 |
Property/Plant/Equipment, Total - Net | 100.3 | 87 | 76.4 | 58.4 | 45.3 |
Property/Plant/Equipment, Total - Gross | 161.9 | 140 | 127.8 | 100.8 | 84.1 |
Accumulated Depreciation, Total | -61.6 | -53 | -51.4 | -42.4 | -38.8 |
Goodwill, Net | 245.4 | 236.1 | 253.8 | 245.7 | 229.3 |
Intangibles, Net | 485.1 | 479.7 | 438.4 | 434.9 | 480.5 |
Long Term Investments | 15.8 | 17.1 | 17.4 | 10.1 | 10.5 |
Other Long Term Assets, Total | 2.3 | 2 | 2.7 | 0.9 | 3.8 |
Total Current Liabilities | 158.7 | 155.8 | 137.3 | 118.1 | 91.6 |
Accounts Payable | 46 | 35.2 | 34.6 | 31.9 | 33 |
Accrued Expenses | 87.7 | 74.4 | 60.5 | 61.7 | 30.4 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3.3 | 3.1 | 4.6 | 1.2 | 1.2 |
Other Current Liabilities, Total | 21.7 | 43.1 | 37.6 | 23.3 | 27 |
Total Liabilities | 626.5 | 581.2 | 600.1 | 532.4 | 512.3 |
Total Long Term Debt | 327.3 | 317.6 | 353.1 | 309.6 | 293.3 |
Long Term Debt | 315.2 | 304.8 | 341.3 | 309.6 | 293.3 |
Capital Lease Obligations | 12.1 | 12.8 | 11.8 | 0 | |
Deferred Income Tax | 35.8 | 48.8 | 62.6 | 74.5 | 96.8 |
Minority Interest | 0 | ||||
Other Liabilities, Total | 104.7 | 59 | 47.1 | 30.2 | 30.6 |
Total Equity | 666.8 | 632.9 | 637.5 | 509.1 | 505 |
Common Stock | 1.1 | 1.1 | 1.1 | 1 | 1 |
Additional Paid-In Capital | 413.9 | 411.6 | 409.3 | 277.9 | 359.3 |
Retained Earnings (Accumulated Deficit) | 248.4 | 232.1 | 210.8 | 208.6 | 127.3 |
Treasury Stock - Common | -0.4 | ||||
Other Equity, Total | 3.4 | -11.9 | 16.3 | 21.6 | 17.8 |
Total Liabilities & Shareholders’ Equity | 1293.3 | 1214.1 | 1237.6 | 1041.5 | 1017.3 |
Total Common Shares Outstanding | 108.393 | 108.215 | 108.011 | 102.652 | 102.33 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Käibevarad kokku | 459.3 | 444.4 | 376 | 392.2 | 370.8 |
Raha ja lühiajalised investeeringud | 87.9 | 120.9 | 123.7 | 118.4 | 139 |
Raha ja ekvivalendid | |||||
Laekumata arved, neto | 147.6 | 147.8 | 99.9 | 124.3 | 91.2 |
Accounts Receivable - Trade, Net | 125.9 | 136.8 | 85.6 | 106.7 | 87 |
Total Inventory | 223.8 | 175.7 | 149.4 | 149.5 | 140.6 |
Total Assets | 1744.3 | 1293.3 | 1177.7 | 1214.1 | 1205.9 |
Property/Plant/Equipment, Total - Net | 155.3 | 100.3 | 92.3 | 87 | 78.9 |
Intangibles, Net | 1111.2 | 730.5 | 689.4 | 715.8 | 734.9 |
Long Term Investments | 15.4 | 15.8 | 17.7 | 17.1 | 17 |
Other Long Term Assets, Total | 3.1 | 2.3 | 2.3 | 2 | 4.3 |
Total Current Liabilities | 168.4 | 158.7 | 129.2 | 155.8 | 133.1 |
Payable/Accrued | 139.3 | 136.8 | 99.9 | 113.5 | 111 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3.2 | 3.3 | 3.1 | 3.1 | 3.9 |
Other Current Liabilities, Total | 25.9 | 18.6 | 26.2 | 39.2 | 18.2 |
Total Liabilities | 902.6 | 626.5 | 538.6 | 581.2 | 580.5 |
Total Long Term Debt | 508 | 325.8 | 313.7 | 315.5 | 339.1 |
Long Term Debt | 508 | 325.8 | 313.7 | 315.5 | 339.1 |
Deferred Income Tax | 124.8 | 35.8 | 43.4 | 48.8 | 59.6 |
Other Liabilities, Total | 101.4 | 106.2 | 52.3 | 61.1 | 48.7 |
Total Equity | 841.7 | 666.8 | 639.1 | 632.9 | 625.4 |
Common Stock | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
Additional Paid-In Capital | 594.7 | 413.9 | 413.3 | 411.6 | 410.6 |
Retained Earnings (Accumulated Deficit) | 235.4 | 248.4 | 242.3 | 232.1 | 210.9 |
Treasury Stock - Common | 0 | ||||
Other Equity, Total | 10.5 | 3.4 | -17.6 | -11.9 | 2.8 |
Total Liabilities & Shareholders’ Equity | 1744.3 | 1293.3 | 1177.7 | 1214.1 | 1205.9 |
Total Common Shares Outstanding | 113.837 | 108.393 | 108.365 | 108.215 | 108.011 |
Cash | 87.9 | 120.9 | 123.7 | 118.4 | 139 |
Other Current Assets, Total | 0 | 3 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | 95.5 | 84 | 52.2 | 39 | 34.1 |
Raha majandustegevusest | 122.9 | 89.1 | 106.4 | 81.8 | 64 |
Raha majandustegevusest | 11.1 | 11 | 9.9 | 5.7 | 4.8 |
Amortization | 78 | 4.5 | 4.3 | 4.1 | 2.6 |
Mittelikviidsed varad | 6.5 | 77.7 | 69.8 | 79 | 63.1 |
Cash Taxes Paid | 32.9 | 43.9 | 12.9 | 17.3 | 11.5 |
Makstud intressid | 7.5 | 8.2 | 8.2 | 9.2 | 5.7 |
Muutused tööjõus | -68.2 | -88.1 | -29.8 | -46 | -40.6 |
Tulu investeeringutelt | -78.3 | -136.1 | -81.5 | -61.9 | -241.7 |
Kapitalikulutused | -77.6 | -134.8 | -49.2 | -22.5 | -12.6 |
Muud rahavood investeeringutelt, kokku | -0.7 | -1.3 | -32.3 | -39.4 | -229.1 |
Rahavood investeeringutelt | -46.1 | -55.1 | 118.9 | -20.1 | 193.8 |
Rahavoogudesse investeerimine | 0 | -1.7 | -0.2 | -3.9 | |
Total Cash Dividends Paid | -44.8 | -37.9 | -33.3 | -28.4 | -21.8 |
Aktsiate emiteerimine (tagasiost), neto | 2.3 | 2.3 | 131.5 | 1.2 | 103.3 |
Laenu väljastamine (kustutamine), neto | -3.6 | -19.5 | 22.4 | 7.3 | 116.2 |
Muutused valuutakursside kõikumisest | 4 | -6.9 | 3.3 | 0.8 | 2.4 |
Rahaline kogumuutus | 2.5 | -109 | 147.1 | 0.6 | 18.5 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 44.6 | 95.5 | 57.4 | 84 | 40.3 |
Cash From Operating Activities | 51.5 | 122.9 | 88.1 | 89.1 | 58.1 |
Cash From Operating Activities | 6.2 | 11.1 | 5.2 | 11 | 5.3 |
Amortization | 39.3 | 78 | 37.6 | 4.5 | 2.1 |
Non-Cash Items | 3.9 | 6.5 | 1.4 | 77.7 | 41.2 |
Cash Taxes Paid | 10.4 | 32.9 | 11.6 | 43.9 | 22.8 |
Cash Interest Paid | 3.3 | 7.5 | 3.6 | 8.2 | 4.2 |
Changes in Working Capital | -42.5 | -68.2 | -13.5 | -88.1 | -30.8 |
Cash From Investing Activities | -408.2 | -78.3 | -49.8 | -136.1 | -116.2 |
Capital Expenditures | -13.6 | -77.6 | -49.5 | -134.8 | -116.1 |
Other Investing Cash Flow Items, Total | -394.6 | -0.7 | -0.3 | -1.3 | -0.1 |
Cash From Financing Activities | 321.4 | -46.1 | -32 | -55.1 | -27.1 |
Financing Cash Flow Items | 0 | 0 | |||
Total Cash Dividends Paid | -37.4 | -44.8 | -31.8 | -37.9 | -25.9 |
Issuance (Retirement) of Stock, Net | 180.8 | 2.3 | 1.7 | 2.3 | 1.3 |
Issuance (Retirement) of Debt, Net | 178 | -3.6 | -1.9 | -19.5 | -2.5 |
Foreign Exchange Effects | 2.3 | 4 | -1 | -6.9 | -3.2 |
Net Change in Cash | -33 | 2.5 | 5.3 | -109 | -88.4 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 6.2065 | 7068171 | -80726 | 2023-05-31 | LOW |
Aberdeen Asset Managers Ltd. | Investment Advisor/Hedge Fund | 5.5554 | 6326683 | 162540 | 2023-05-31 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.5228 | 5150802 | 17518 | 2023-05-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 3.3567 | 3822794 | -2915681 | 2023-05-31 | LOW |
Brown Capital Management, LLC | Investment Advisor | 3.0657 | 3491373 | 2724385 | 2023-04-25 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.8553 | 3251699 | 254288 | 2023-05-22 | LOW |
Société Générale Securities Services S.A. | Research Firm | 2.7248 | 3103107 | -398577 | 2023-05-31 | LOW |
Ostrum Asset Management | Investment Advisor | 2.3886 | 2720231 | 537826 | 2023-05-26 | MED |
Royal London Asset Management Ltd. | Investment Advisor/Hedge Fund | 2.1928 | 2497299 | -22409 | 2023-05-31 | MED |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 2.1443 | 2442010 | 51151 | 2023-05-31 | LOW |
BNP Paribas Asset Management France SAS | Investment Advisor/Hedge Fund | 2.0511 | 2335828 | 2335828 | 2023-05-31 | LOW |
Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 2.044 | 2327789 | 345928 | 2023-05-31 | LOW |
Grandeur Peak Global Advisors, LLC | Investment Advisor/Hedge Fund | 1.9064 | 2171078 | -743698 | 2023-05-26 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.7375 | 1978717 | -33778 | 2023-05-01 | LOW |
Rathbone Unit Trust Management Limited | Investment Advisor/Hedge Fund | 1.7341 | 1974865 | -59016 | 2023-05-30 | LOW |
La Financière de l'Echiquier | Investment Advisor | 1.4563 | 1658520 | 244342 | 2023-05-31 | LOW |
Baron Capital Management, Inc. | Investment Advisor/Hedge Fund | 1.4077 | 1603118 | -555930 | 2023-02-16 | LOW |
Jarislowsky Fraser, Ltd. | Investment Advisor | 1.2856 | 1464049 | 87770 | 2023-02-16 | LOW |
T. Rowe Price International Ltd | Investment Advisor/Hedge Fund | 1.2713 | 1447821 | 45395 | 2023-05-25 | MED |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.2572 | 1431721 | 27504 | 2023-05-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Dechra Pharmaceuticals Company profile
Ettevõttest Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC tegeleb veterinaarravimite ja nendega seotud toodete äriga. Ettevõte tegeleb veterinaarravimite väljatöötamise, tootmise ja turustamisega. Ettevõtte segmentide hulka kuuluvad Euroopa farmaatsiatooted, Põhja-Ameerika farmaatsiatooted ning farmaatsiatoodete teadus- ja arendustegevus. Euroopa farmaatsiatoodete segment hõlmab Dechra Veterinary Products Europe, Dechra Veterinary Products International ja Dechra Pharmaceuticals Manufacturing. Ta toodab ja turustab lemmikloomade, hobuslaste, toiduainetööstusloomade tooteid ja loomasöötasid. Põhja-Ameerika (NA) farmaatsiatoodete segmenti kuuluvad Dechra Veterinary Products US, Dechra Produtas Veterinarios (Mehhiko) ja Dechra Veterinary Products Canada, mis müüb lemmikloomade, hobuslaste ja toiduks kasutatavate loomade tooteid. Segmendi kuuluvad ka tootmisüksused Melbourne'is (Florida) ja Fort Worthis (Texas).
Industry: | Veterinary Drugs |
24 Cheshire Avenue
Cheshire Business Park
NORTHWICH
CHESHIRE CW9 7UA
GB
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com